Clonal analysis of fetal hematopoietic stem/progenitor cells reveals how post-transplantation capabilities are distributed
Stem Cell Reports · 2024-08 · 19 (8) · 1189-1204
DOI: 10.1016/j.stemcr.2024.07.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Stem Cell Reports, 2024-08. Verfasst von Olivia J Stonehouse und 10 weiteren Autor:innen. Beteiligte Einrichtung: The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia; The University of Melbourne, Melbourne, Victoria, Australia;…. Hauptthemen laut MEDLINE: Hematopoietic Stem Cells, Hematopoietic Stem Cell Transplantation, Cell Lineage. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
It has been proposed that adult hematopoiesis is sustained by multipotent progenitors (MPPs) specified during embryogenesis. Adult-like hematopoietic stem cell (HSC) and MPP immunophenotypes are present in the fetus, but knowledge of their functional capacity is incomplete. We found that fetal MPP populations were functionally similar to adult cells, albeit with some differences in lymphoid output. Clonal assessment revealed that lineage biases arose from differences in patterns of single-/bi-lineage differentiation. Long-term (LT)- and short-term (ST)-HSC populations were distinguished from MPPs according to capacity for clonal multilineage differentiation. We discovered that a large cohort of long-term repopulating units (LT-RUs) resides within the ST-HSC population; a significant portion of these were labeled using Flt3-cre. This finding has two implications: (1) use of the CD150+ LT-HSC immunophenotype alone will significantly underestimate the size and diversity of the LT-RU pool and (2) LT-RUs in the ST-HSC population have the attributes required to persist into adulthood.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia; The University of Melbourne, Melbourne, Victoria, Australia; Lowy Cancer Research Centre, UNSW, Sydney, New South Wales, Australia.
- The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia; The University of Melbourne, Melbourne, Victoria, Australia.
- Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
- Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia; The University of Melbourne Centre for Cancer Research, The University of Melbourne, Melbourne, Victoria, Australi…
- The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia; The University of Melbourne, Melbourne, Victoria, Australia; School of Cellular and Molecular Medicine, University of Bristol, Bri…
Zitieren
APA
Stonehouse, O. J., Biben, C., Weber, T. S., Garnham, A., Fennell, K. A., Farley, A., Terreaux, A. F., Alexander, W. S., Dawson, M. A., Naik, S. H., & Taoudi, S. (2024). Clonal analysis of fetal hematopoietic stem/progenitor cells reveals how post-transplantation capabilities are distributed. Stem Cell Reports, 19(8), 1189-1204. https://doi.org/10.1016/j.stemcr.2024.07.003
Vancouver
Stonehouse OJ, Biben C, Weber TS, Garnham A, Fennell KA, Farley A, et al. Clonal analysis of fetal hematopoietic stem/progenitor cells reveals how post-transplantation capabilities are distributed. Stem Cell Reports. 2024;19(8):1189-1204. doi:10.1016/j.stemcr.2024.07.003
BibTeX
@article{Stonehouse2024,
author = {Stonehouse, Olivia J and Biben, Christine and Weber, Tom S and Garnham, Alexandra and Fennell, Katie A and Farley, Alison and Terreaux, Antoine F and Alexander, Warren S and Dawson, Mark A and Naik, Shalin H and Taoudi, Samir},
title = {Clonal analysis of fetal hematopoietic stem/progenitor cells reveals how post-transplantation capabilities are distributed},
journal = {Stem Cell Reports},
year = {2024},
volume = {19},
number = {8},
pages = {1189--1204},
doi = {10.1016/j.stemcr.2024.07.003}
}
EUVIMED